Last reviewed · How we verify
LY900014-U200
At a glance
| Generic name | LY900014-U200 |
|---|---|
| Also known as | Ultra-Rapid Lispro |
| Sponsor | Eli Lilly and Company |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Compare 2 Formulations of LY900014 in Healthy Participants (PHASE1)
- Study to Compare 2 Formulations of LY900014 in Healthy Participants (PHASE1)
- A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |